Journal de Pharmacologie 1982-01-01

Action of clofoctol on bacterial cell wall synthesis.

F Yablonsky, G Simonnet

Index: J. Pharmacol. 13(4) , 515-24, (1982)

Full Text: HTML

Abstract

Clofoctol inhibits in vivo cell wall synthesis of B. subtilis and gives rise to an accumulation of UDP-N-acetyl-muramyl pentapeptide. However, in vitro peptidoglycan synthesis using a particulate membrane preparation is not inhibited by clofoctol. These results suggest that clofoctol does not inhibit a specific enzyme of the cell wall synthesis, and that the inhibition of the cell wall synthesis might be a secondary effect due to a disturbance of the cytoplasmic membrane.

Related Compounds

  • Clofoctol

Related Articles:

Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer.

2014-10-01

[Br. J. Pharmacol. 171(19) , 4478-89, (2014)]

A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assay.

1988-01-01

[Drugs Exp. Clin. Res. 14(1) , 39-43, (1988)]

Alteration of membrane permeability in Bacillus subtilis by clofoctol.

1983-04-01

[J. Gen. Microbiol. 129(4) , 1089-95, (1983)]

[Pharmacokinetic study of an antibacterial agent: clofoctol after intravenous administration in the rabbit (author's transl)].

1982-01-01

[J. Pharm. Belg. 37(1) , 72-7, (1982)]

In vitro and in vivo pharmacokinetic/pharmacodynamic activity of clofoctol.

2012-08-01

[J. Chemother. 24(4) , 201-6, (2012)]

More Articles...